Petros Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 11/14/2022 | 255.91 K | $131.00 K | 114.80% | 1.24% |
| BLACKROCK INC. | 11/14/2022 | 165.10 K | $84.00 K | 0.00% | 0.80% |
| CITADEL ADVISORS LLC | 11/14/2022 | 163.60 K | $83.00 K | 935.44% | 0.79% |
| CITADEL ADVISORS LLC | 11/14/2022 | 87.32 K | $45.00 K | 22.29% | 0.42% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/14/2022 | 76.65 K | $39.00 K | 1.71% | 0.37% |
| STATE STREET CORP | 11/15/2022 | 45.44 K | $23.00 K | 0.00% | 0.22% |
| JANE STREET GROUP, LLC | 11/15/2022 | 32.81 K | $17.00 K | 100.00% | 0.16% |
| J. GOLDMAN & CO LP | 11/14/2022 | 31.25 K | $0 | 0.00% | 0.15% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2022 | 28.50 K | $15.00 K | 100.00% | 0.14% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2022 | 18.00 K | $9.00 K | -80.12% | 0.09% |
| CITADEL ADVISORS LLC | 11/14/2022 | 15.00 K | $8.00 K | 4.17% | 0.07% |
| EMFO, LLC | 10/31/2022 | 10.00 K | $5.00 K | 0.00% | 0.05% |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 10/13/2022 | 1.20 K | $1.00 K | 0.00% | 0.01% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2022 | 1.14 K | $1.00 K | 0.00% | 0.01% |
| MORGAN STANLEY | 11/14/2022 | 169 | $0 | 0.00% | 0.00% |
| FIRST MANHATTAN CO. LLC. | 11/14/2022 | 100 | $0 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 11/14/2022 | 99 | $0 | 10.00% | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 11/15/2022 | 0 | $0 | 0.00% | 0.00% |
| VERITABLE, L.P. | 11/14/2022 | 0 | $0 | -100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 11/04/2022 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 11/07/2022 | 0 | $0 | -100.00% | 0.00% |
| CUTLER GROUP LLC / CA | 10/25/2022 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Petros Pharmaceuticals, Inc. institutional Ownership - FAQ's
3.35% of Petros Pharmaceuticals, Inc. stock is owned by institutional investors.